The recent addition of the Caris Assure liquid biopsy (Fig. 2) means the company can offer patients and biopharma partners access to a non-invasive liquid-profiling option. It also means that its ...
Hosted on MSN8mon
An exosome-based liquid biopsy shows promise for early detection of pancreatic cancerAn investigational exosome-based liquid biopsy accurately detected 97% of stage 1-2 pancreatic cancers when combined with the biomarker CA 19-9, according to research presented at the American ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback